Andere talen Telo Genomics Corp.

Aandelen

TELO

CA87975M2085

Beurs gesloten - Toronto S.E. Andere beurzen 21:57:14 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,17 ^CAD	-5,56%		0,00%	-15,00%

10/04	Telo Genomics ontvangt accreditatie van College of American Pathologists	MT
10/04	Telo Genomics Corp. Accreditatie verleend door College of American Pathologists	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Telo Genomics Receives Accreditation from College of American Pathologists	10/04
Telo Genomics Receives Accreditation from College of American Pathologists	10/04
Telo Genomics Corp. Receives Accreditation from College of American Pathologists	10/04
Telo Genomics' MRD Clinical Trial Expands into Multi-Center Trial; Shares up 9.5%	02/04
Telo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial	02/04
Telo Genomics Corp. Announces Patient Recruitment for Its Minimal Respiratory Disease Clinical Trial Has Been Initiated, with Several Patient Samples Received and Processed to Date	02/04
Telo Genomics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	27/02
Telo Genomics Corp. Initiates MRD Clinical Trial for Multiple Myeloma Patients	13/02
Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients	13/02
Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US	30/01
Telo Genomics Corp. Announces Executive Changes	09/12
Telo Genomics Gears up for American Society of Hematology Conference	06/12
Telo Genomics Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023	22/11
Telo Genomics Launches Physician Experience Program in the United States	16/11
Telo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists	07/11
Telo Genomics Corp. Announces the American Society of Hematology Accepts the Results of Teloview-Smm Technical Repeatability Validation for Presentation At Their Annual Meeting in December 10, 2023	01/11
American Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting	01/11
Telo Genomics Corp. Reports Earnings Results for the Full Year Ended June 30, 2023	31-10-23
Telo Genomics : Consolidated Financial Statements	30-10-23
Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation	26-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Telo Genomics Corp.

Aandelen

TELO

CA87975M2085

Andere talen

Filters